These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 34977519

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N, Baker SS, Chapa-Rodriguez A, Liu W, Nugent CA, Tsompana M, Mastrandrea L, Buck MJ, Baker RD, Genco RJ, Zhu R, Zhu L.
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK.
    World J Gastroenterol; 2020 Dec 07; 26(45):7153-7172. PubMed ID: 33362374
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1.
    Rizzolo D, Kong B, Taylor RE, Brinker A, Goedken M, Buckley B, Guo GL.
    Acta Pharm Sin B; 2021 Dec 07; 11(12):3847-3856. PubMed ID: 35024311
    [Abstract] [Full Text] [Related]

  • 30. Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.
    Abdelmalek MF, Sanyal AJ, Nakajima A, Neuschwander-Tetri BA, Goodman ZD, Lawitz EJ, Harrison SA, Jacobson IM, Imajo K, Gunn N, Halegoua-DeMarzio D, Akahane T, Boone B, Yamaguchi M, Chatterjee A, Tirucherai GS, Shevell DE, Du S, Charles ED, Loomba R.
    Clin Gastroenterol Hepatol; 2024 Jan 07; 22(1):113-123.e9. PubMed ID: 37088458
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta4-cholenoic acid oxidoreductases.
    Kang DJ, Ridlon JM, Moore DR, Barnes S, Hylemon PB.
    Biochim Biophys Acta; 2008 Jan 07; 1781(1-2):16-25. PubMed ID: 18047844
    [Abstract] [Full Text] [Related]

  • 33. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
    Harrison SA, Ruane PJ, Freilich B, Neff G, Patil R, Behling C, Hu C, Shringarpure R, de Temple B, Fong E, Tillman EJ, Rolph T, Cheng A, Yale K.
    JHEP Rep; 2023 Jan 07; 5(1):100563. PubMed ID: 36644237
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
    Tiessen RG, Kennedy CA, Keller BT, Levin N, Acevedo L, Gedulin B, van Vliet AA, Dorenbaum A, Palmer M.
    BMC Gastroenterol; 2018 Jan 05; 18(1):3. PubMed ID: 29304731
    [Abstract] [Full Text] [Related]

  • 36. Pegbelfermin, a PEGylated FGF21 analogue, has pharmacology without bone toxicity after 1-year dosing in skeletally-mature monkeys.
    Thompson KE, Guillot M, Graziano MJ, Mangipudy RS, Chadwick KD.
    Toxicol Appl Pharmacol; 2021 Oct 01; 428():115673. PubMed ID: 34364948
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver disease.
    Huang J, Lin H, Liu AN, Wu W, Alisi A, Loomba R, Xu C, Xiang W, Shao J, Dong G, Zheng MH, Fu J, Ni Y.
    Liver Int; 2024 Oct 01; 44(10):2793-2806. PubMed ID: 39082260
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.